In a thought-provoking piece, a Monmouthshire mother reflects on her experience with ovarian cancer and the potential impact of living in England. Heather Morgan, 59, believes her diagnosis and subsequent treatment could have been vastly different if she had been a resident of England, where she would have been eligible for a life-saving genetic test. This test, not available in Wales, could have identified her BRCA1 gene mutation, significantly reducing her risk of developing both breast and ovarian cancer.
Morgan's story highlights a stark disparity in healthcare across the English-Welsh border. The Welsh government's commitment to meeting NICE guidelines was evident, but the practicalities of increasing testing capacity meant that Morgan, like many others, was not offered the potentially life-saving test. By the time the rules were changed to align with England, Morgan had already completed her treatment and was not invited for the test.
This situation is not unique to Morgan. The National Hereditary Breast Cancer Helpline, a charity providing support to those with inherited cancers, has seen the impact of such disparities. Founder Wendy Watson notes that the postcode lottery of healthcare is a real concern, with discrepancies existing not only between England and Wales but also between different health boards and trusts within England.
The BRCA1 and BRCA2 gene mutations are of particular interest. These mutations significantly increase the risk of developing certain cancers, including breast and ovarian. According to the NHS, women in the UK have a 12.5% chance of developing breast cancer and a 2% chance of developing ovarian cancer in their lifetimes. For those with BRCA1 gene alterations, these risks increase to 72% and 44%, respectively, while for BRCA2 gene alterations, the risks are 69% and 17%.
The implications of these mutations are profound, and the NICE guidance recommends annual MRIs for women with BRCA gene mutations from the age of 30 to 49, with annual mammograms possible from 40 onwards. However, the reality for many, like Morgan and Louise Owen, is a complex web of conflicting advice and discrepancies in healthcare provision.
Owen, a 36-year-old mother, has known for over a decade that she carries the BRCA2 gene mutation. When she turned 30, she had her first MRI as part of the screening available for those with an inherited risk. However, she was told that subsequent annual MRIs were not possible while she was breastfeeding, despite her research suggesting they were safe. This decision left her feeling angry and frustrated, as she felt she should not have to choose between screening and breastfeeding.
The All-Wales programme for screening high-risk women was rolled out earlier this year, aiming to provide a consistent service across Wales. However, the most recent guidance from the Royal College of Radiologists recommends against MRI or mammogram screening during pregnancy, citing reduced sensitivity and the potential for incorrect results. This guidance, while important, also highlights the challenges faced by women like Morgan and Owen, who must navigate a complex healthcare system with varying standards and practices.
In conclusion, the story of Heather Morgan and others like her underscores the importance of consistent and accessible healthcare across borders and regions. The postcode lottery of healthcare is a real concern, and the need for clear, consistent guidance and practices is paramount. As we reflect on these disparities, we must also consider the broader implications for public health and the potential long-term impact on individuals and communities.
